Myoferlin Is a Key Regulator of EGFR Activity in Breast Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-13-1142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Is microRNA-31 a Key Regulator of Breast Tumorigenesis?

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2018English

miR-141-3p Is a Key Negative Regulator of the EGFR Pathway in Osteosarcoma

OncoTargets and Therapy
OncologyPharmacology
2018English

miR-195 Is a Key Regulator of Raf1 in Thyroid Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Phosphorylation of WASp Is a Key Regulator of Activity and Stability in Vivo

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2009English

miR-139-5p Is a Regulator of Metastatic Pathways in Breast Cancer

RNA
Molecular Biology
2013English

SPARC Is a Key Regulator of Proliferation, Apoptosis and Invasion in Human Ovarian Cancer

PLoS ONE
Multidisciplinary
2012English

STAT3 Is a Key Transcriptional Regulator of Cancer Stem Cell Marker CD133 in HCC

HepatoBiliary Surgery and Nutrition
2016English

The ShcA Adaptor Protein Is a Critical Regulator of Breast Cancer Progression

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2008English

CD44 Correlates With Clinicopathological Characteristics and Is Upregulated by EGFR in Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy